PRS3 COMBINATION THERAPY [LONG ACTING BETA AGONISTS (LABA) PLUS INHALED CORTICOSTEROIDS] VERSUS LABA ALONE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE- AN ECONOMIC ANALYSIS
Abstract
Authors
I Mayers P Jacobs D Marciniuk A Chuck J Varney